Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 6
2006 4
2007 7
2008 9
2009 13
2010 8
2011 8
2012 7
2013 11
2014 7
2015 14
2016 11
2017 14
2018 11
2019 13
2020 12
2021 6
2022 4
2023 10
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

159 results

Results by year

Filters applied: . Clear all
Page 1
A phase II clinical trial of toripalimab combined with neoadjuvant chemoradiotherapy in locally advanced esophageal squamous cell carcinoma (NEOCRTEC1901).
Chen R, Liu Q, Li Q, Zhu Y, Zhao L, Liu S, Chen B, Liu M, Hu Y, Lin T, Li J, Chen J, Lv Y, Fu J, Xi M, Yang H. Chen R, et al. Among authors: liu m. EClinicalMedicine. 2023 Jul 26;62:102118. doi: 10.1016/j.eclinm.2023.102118. eCollection 2023 Aug. EClinicalMedicine. 2023. PMID: 37560259 Free PMC article.
Efficacy and cost-effectiveness analysis of pretreatment percutaneous endoscopic gastrostomy in unresectable locally advanced esophageal cancer patients treated with concurrent chemoradiotherapy (GASTO 1059).
Ai X, Zhang P, Xie X, Qiu B, Zhu Y, Zhao L, Xi M, Wu Y, Guo S, Guo J, Liu F, Wang D, Chen N, He Q, Hu Y, Liu M, Ding Z, Liu H. Ai X, et al. Among authors: liu m. Cancer Med. 2023 Jul;12(14):15000-15010. doi: 10.1002/cam4.6136. Epub 2023 Jun 16. Cancer Med. 2023. PMID: 37326436 Free PMC article. Clinical Trial.
A Surrogate Endpoint for Overall Survival in Locally Advanced and Resectable Esophageal Squamous Cell Carcinoma: A Reanalysis of Data From the NEOCRTEC5010 Trial.
Gao T, Yang Y, Zhang Z, Yang Y, Liu S, Hu Y, Zhu Y, Yang H, Fu J, Wang J, Lin T, Xi M, Li Q, Liu M, Zhao L. Gao T, et al. Among authors: liu m. Int J Radiat Oncol Biol Phys. 2023 Nov 15;117(4):809-820. doi: 10.1016/j.ijrobp.2023.05.021. Epub 2023 May 19. Int J Radiat Oncol Biol Phys. 2023. PMID: 37210047 Free article.
Prognostic value of recurrence pattern in locally advanced esophageal squamous cell carcinoma: Results from the phase III trial NEOCRTEC5010.
Chen D, Kong M, Sun J, Yang H, Chen Y, Fang W, Yu Z, Mao W, Xiang J, Han Y, Chen Z, Yang H, Wang J, Pang Q, Zheng X, Yang H, Li T, Zhang X, Li Q, Wang G, Mao T, Guo X, Lin T, Liu M, Witharana P, Fu J, Chen B, Shen J, Zhu C. Chen D, et al. Among authors: liu m. J Thorac Cardiovasc Surg. 2023 Mar;165(3):888-897. doi: 10.1016/j.jtcvs.2022.08.009. Epub 2022 Aug 20. J Thorac Cardiovasc Surg. 2023. PMID: 36137841 Clinical Trial.
159 results